Latest Retro Biosciences News & Updates

See the latest news and media coverage for Retro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Retro Biosciences (Retro)

Biotechnology company extending healthy human lifespan

retro.bio
Headquarters
Redwood City, United States
Company type
Private company
Number of employees
90–200
Industry
Pharmaceuticals

Last updated

Latest news about Retro Biosciences (Retro)

In short: Retro became a clinical-stage biotech company after launching human trials for an Alzheimer's drug and securing new funding rounds.

Company announcements

Retro

Retro announces initial close of financing

The round values the company at $1.8 billion, led by 4P Capital, funding RTR242's clinical advancement and expansion of cell therapy, AI protein engineering, and manufacturing capabilities.

Retro

Retro Bio announces collaboration with MCRI

The partnership aims to develop preventative medicine by rejuvenating the blood system using a person's genetics to extend healthy lifespan by 10 years.

Unlock all announcements with a

Media coverage

Nature

This method to reverse cellular ageing is about to be tested in humans

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs.

Unlock all articles with a

Never miss news about Retro

Track Retro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Retro competitors & trending companies

Browse news for competitors to Retro and other trending companies.